Cargando…

Experience with β-d-Glucan Assay for Diagnosis of Invasive Candidiasis in ICU Patients: Pilot Study from India

BACKGROUND: β-d-Glucan assay (BDG) has been recently introduced in India and is recommended for the early diagnosis of invasive candidiasis (IC), but there are a number of factors (eg β-lactam antibiotics, immunoglobulin and albumin infusions, bacteremia and surgical mesh) which may falsely elevate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bansal, Nitin, Gopalakrishnan, Ram, Sethuraman, Nandini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631234/ http://dx.doi.org/10.1093/ofid/ofx163.1607

Ejemplares similares

Experience with β-D-Glucan Assay in the Management of Critically ill Patients with High Risk of Invasive Candidiasis: An Observational Study
por: Bansal, Nitin, et al.
Publicado: (2018)

396. Clinical Features of Proven and Probable Cases of Histoplasmosis and the Role of Urinary Histoplasma Antigen Testing: A Case Series From India
por: Bansal, Nitin, et al.
Publicado: (2018)

Diagnosis of invasive candidiasis in the ICU
por: Eggimann, Philippe, et al.
Publicado: (2011)

β-D-Glucan Assay in Diagnosis and Monitoring the Systemic Candidiasis in a Rat Model
por: Khodadadi, Hossein, et al.
Publicado: (2014)

360. The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
por: Son, Hyo-Ju
Publicado: (2022)

Clinical Profile of Non-neutropenic Patients with Invasive Candidiasis: A Retrospective Study in a Tertiary Care Center
por: Sridharan, Sowmya, et al.
Publicado: (2021)

Clinical profile of respiratory viral infections: A study from tertiary care centre of South India
por: Rao, P Vishnu, et al.
Publicado: (2017)

Utility of Serial β-d-Glucan Levels in Patients with High Risk for Invasive Candidiasis: A Potential Tool for Antifungal Stewardship
por: Chua, Alvin Qijia, et al.
Publicado: (2017)

2044. Utility of Serum Β-D Glucan Assay for Diagnosis of Invasive Fungal Infections in Solid Organ Transplant Recipients
por: Vijayvargiya, Prakhar, et al.
Publicado: (2018)

2170. Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Gram-Negative Bacteremia
por: Rajendran, Surendran, et al.
Publicado: (2019)

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study
por: Hanson, Kimberly E., et al.
Publicado: (2012)

Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy
por: Calandra, Thierry, et al.
Publicado: (2016)

418. Evaluation of β-d-Glucan (BG) and Galactomannan (GM) Detection Assays in the Diagnosis of Invasive Fungal Infections in High-Risk Pediatric Cancer Patients
por: Alali, Muayad, et al.
Publicado: (2018)

Breakthrough Invasive Candidiasis in Children
por: Dong, Sara, et al.
Publicado: (2017)

Performance of Repeated Measures of (1–3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial
por: Dupuis, Claire, et al.
Publicado: (2021)

250. Comparison of T2Candida Assay with Blood Culture, Candida Sepsis Score and Serum β-d-glucan in Diagnosis of Candidemia
por: Nizami, Sobia, et al.
Publicado: (2019)

Serum 1,3-βD-Glucan assay in the diagnosis of invasive fungal disease in neonates
por: Mackay, Cheryl Anne, et al.
Publicado: (2011)

115. The Utility of (1→3)-β-D-glucan Assay in the Diagnosis of Severe Coccidioidomycosis Infections among Immunocompromised Hosts
por: Ayazi, Parham, et al.
Publicado: (2021)

Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis?
por: Eggimann, Philippe, et al.
Publicado: (2011)

The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis
por: Guo, Junfei, et al.
Publicado: (2019)

(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial
por: De Pascale, Gennaro, et al.
Publicado: (2020)

Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases
por: De Carolis, Elena, et al.
Publicado: (2020)

Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011)

2043. T2-Candida (T2MR) vs. Β-D-Glucan (BDG) for Preemptive Antifungal Stewardship in the Intensive Care Unit (ICU)
por: Gill, Christian, et al.
Publicado: (2018)

Diagnosis and Treatment of Invasive Candidiasis
por: Barantsevich, Natalia, et al.
Publicado: (2022)

Letter on “(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial”
por: Kritikos, Antonios, et al.
Publicado: (2021)

Safety and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children
por: Roilides, Emmanuel, et al.
Publicado: (2017)

1688. Invasive Ocular Candidiasis: Who Is Really at Risk?
por: Seidelman, Jessica, et al.
Publicado: (2019)

808. Outcomes of Invasive Candidiasis Stratified by Antifungal Therapy
por: Box, Maggie, et al.
Publicado: (2023)

316. Use of (1-3)-β-D-Glucan Assay for Diagnosis of Candidemia in Patients Hospitalized with SARS-CoV-2 Infection
por: Malik, Yesha, et al.
Publicado: (2021)

Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study)
por: Ramos, Jose Tomas, et al.
Publicado: (2017)

P392 Comparative evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal infections
por: Singh, Shreya, et al.
Publicado: (2022)

Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions
por: León, Cristóbal, et al.
Publicado: (2016)

Clinical prediction rules for invasive candidiasis in the ICU: ready for prime time?
por: Ostrosky-Zeichner, Luis
Publicado: (2011)

P307 Clinical profile of fusarium infections: case series from a tertiary care hospital
por: Vineeth, VK, et al.
Publicado: (2022)

The Comparative Evaluation of the Fujifilm Wako β-Glucan Assay and Fungitell Assay for Diagnosing Invasive Fungal Disease
por: Singh, Shreya, et al.
Publicado: (2022)

Molecular Methods for the Diagnosis of Invasive Candidiasis
por: Camp, Iris, et al.
Publicado: (2020)

A real time PCR assay on blood for diagnosis of invasive candidiasis in immunocompromised patient
por: Ashrafi, M, et al.
Publicado: (2015)

Diagnostic performance of the (1–3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers
por: Son, Hyo-Ju, et al.
Publicado: (2017)

Erratum to: Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions
por: León, Cristóbal, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gfgnsbeg34r93gq97nq52fpu5n